Animal models of fulminant hepatic failure: A critical evaluation

Liver Transplantation

Volumn 6, Issue 1, 2000, Pages 21-31

  Newsome, Philip Noel ^a   Plevris, John Nicholas ^a   Nelson, Leonard Joseph ^a   Hayes, Peter Clive ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSAMINE; PARACETAMOL;

ANIMAL MODEL; DEVASCULARIZATION; INFLAMMATION; LIVER FAILURE; LIVER TOXICITY; MEDICAL RESEARCH; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; REFRACTORY ANEMIA; REPRODUCIBILITY; REVIEW; SURGERY;

EID: 0034089243     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500060110     Document Type: Review

References (70)

1. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970;3:282-298.
2. Plevris JN, Schina M, Hayes PC. Review article: The management of acute liver failure. Aliment Pharmacol Ther 1998;12: 405-418.
3. Terblanche J, Hickman R. Animal models of fulminant hepatic failure. Dig Dis Sci 1991;36:770-774.
4. Minkowski O, Naunyn B. Ueber den Icterus durch Polycholie und die Vorgange in der Leber bei demselben. Arch Exp Path Pharmakol 1886;21:1-33.
5. Minkowski O. Ueber den Einfluss der Leber-exstirpation auf den Stoffwechsel. Arch Exp Path Pharmakol 1886;21:41-87.
6. Mann FC, Magath TB. The effect of total removal of the liver. Tr Sec Path Physiol Am Med Assoc 1921:29-42.
7. Mann FC. The effects of complete and partial removal of the liver. Medicine 1927;6:419-511.
8. Hahn M, Massen O, Nencki M, Pawlow J. Die Eck'sche Fistel und ihre Folgen fur den Organismus. Arch Exp Path Pharmakol 1893;32:161-210.
9. Hickman R, Dent DM, Terblanche J. The anhepatic model in a pig. S Afr Med J 1974;48:263-274.
10. Lempinen M, Soyer T, Eiseman B. A new technique for preparing totally hepatectomized pigs. Surgery 1973;73:463-467.
11. Chandrasakeram AK, Beaudoin JG, Slapak M. The effect of auxiliary liver transplantation on posthepatectomy coma in the dog. Arch Surg 1971;103:728-734.
12. Filipponi F, Boggi U, Meacci L, Burchielli S, Vistoli F, Bellini R, et al. A new technique for total hepatectomy in the pig for testing liver support devices. Surgery 1999;125:448-455.
13. Olafsson S, Gottstein J, Blei AT. Brain edema and intracranial hypertension in rats after total hepatectomy. Gastroenterology 1995;108:1097-1103.
14. Nyberg SL, Shirabe K, Peshwa MV, Sielaff TD, Crotty PL, Mann HJ, et al. Extracorporeal application of a gel-entrapment, bioartificial liver: Demonstration of drug metabolism and other biochemical functions. Cell Transplant 1993;2:441-452.
15. Tonnesen K. Experimental liver failure. A comparison between hepatectomy and hepatic devascularizarion in the pig. Acta Chir Scand 1977;143:271-277.
16. Hanid MA, Mackenzie RL, Jenner RE, Chase RA, Mellon PJ, Trewby PN, et al. Intracranial pressure in pigs with surgically induced acute liver failure. Gastroenterology 1979;76:123-131.
17. Rozga J, Williams F, Ro MS, Neuzil DF, Giorgio TD, Backfisch G, et al. Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 1993;17:258-265.
18. de Groot GH, Reuvers CB, Schalm SW, Boks AL, Terpstra OT, Jeekel H, et al. A reproducible model of acute hepatic failure by transient ischemia in the pig. J Surg Res 1987;42:92-100.
19. Jalan R, Olde-Damink SWM, Deutz NEP, Lee A, Hayes PC. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999;354:1164-1168.
20. Leenhoff JV, Hickman R, Saunders SJ, Terblanche J. Massive liver cell necrosis induced in the pig with carbon tetrachloride. S Afr Med J 1974;48:1201-1204.
21. Mourelle M, Villalon C, Amezcua JL. Protective effect of colchicine on acute liver damage induced by carbon tetrachloride. J Hepatol 1988;6:337-342.
22. Peeling J, Shoemaker L, Gauthier T, Benarroch A, Sutherland GR, Minuk GY. Cerebral metabolic and histological effects of thioacetamide-induced liver failure. Am J Physiol 1993;265: G572-G578.
23. Maddison JE, Watson WE, Dodd PR, Johnston GA. Alterations in cortical [3H]kainate and alpha-[3H]amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding in a spontaneous canine model of chronic hepatic encephalopathy. J Neurochem 1991;56:1881-1888.
24. Sutherland DE, Numata M, Matas AJ, Simmons RL, Najarian JS. Hepatocellular transplantation in acute liver failure. Surgery 1977;82:124-132.
25. Smith JS, Harrison GG. The effects of multiple anaesthetics on the livers of rats subjected to microsomal enzyme induction. A preliminary report. S Afr Med J 1973;47:797-799.
26. Harrison GG, Smith JS. Massive lethal hepatic necrosis in rats anesthetized with fluroxene, after microsomal enzyme induction. Anesthesiology 1973;39:619-625.
27. Farivar M, Wands JR, Isselbacher KJ, Bucher NL. Beneficial effect of insulin and glucagon in fulminant murine viral hepatitis [letter]. Lancet 1976;1:696-697.
28. Farivar M, Wands JR, Isselbacher KJ, Bucher NL. Effect of insulin and glucagon on fulminant murine hepatitis. N Engl J Med 1976;295:1517-1519.
29. Blitzer BL, Waggoner JG, Jones EA, Gralnick HR, Towne D, Butler J, et al. A model of fulminant hepatic failure in the rabbit. Gastroenterology 1978;74:664-671.
30. Kalpana K, Ong HS, Soo KC, Tan SY, Raj JP. An improved model of galactosamine-induced fulminant hepatic failure in the pig. J Surg Res 1999;82:121-130.
31. Keppler D, Lesch R, Reutter W, Decker K. Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol 1968;9: 279-290.
32. Sielaff TD, Hu MY, Rollins MD, Bloomer JR, Amiot B, Hu WS, et al. An anesthetized model of lethal canine galactosamine fulminant hepatic failure. Hepatology 1995;21:796-804.
33. Sielaff TD, Hu MY, Amiot B, Rollins MD, Rao S, McGuire B, et al. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J Surg Res 1995;59:179-184.
34. Diaz-Buxo JA, Blumenthal S, Hayes D, Gores P, Gordon B. Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines. Hepatology 1997;25:950-957.
35. Nyberg SL. Galactosamine-induced fulminant hepatic failure. Hepatology 1997;26:1367-1369.
36. Nyberg SL, Cerra FB, Gruetter R. Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog. Liver Transpl Surg 1998;4:158-165.
37. Gazzard BG, Hughes RD, Mellon PJ, Portmann B, Williams R. A dog model of fulminant hepatic failure produced by paracetamol administration. Br J Exp Pathol 1975;56:408-411.
38. Grosse H, Ozier Y, Fabre M, Cherruau B, Abbas A, Urbani L, et al. Acetaminophen-induced fulminant hepatic failure in pigs. A new model to assess pre-clinical liver assistance [abstract]. Hepatology 1996;24:722A.
39. Henne-Bruns D, Artwohl J, Broelsch C, Kremer B. Acetaminophen-induced acute hepatic failure in pigs: Controversial results to other animal models. Res Exp Med (Berl) 1988;188:463-472.
40. Kelly JH, Koussayer T, He DE, Chong MG, Shang TA, Whisennand HH, et al. An improved model of acetaminophen-induced fulminant hepatic failure in dogs. Hepatology 1992;15: 329-335.
41. Miller DJ, Hickman R, Fratter R, Terblanche J, Saunders SJ. An animal model of fulminant hepatic failure: A feasibility study. Gastroenterology 1976;71:109-113.
42. Ortega L, Landa Garcia JI, Torres GA, Silecchia G, Arenas J, Suarez A, et al. Acetaminophen-induced fulminant hepatic failure in dogs. Hepatology 1985;5:673-676.
43. Walker RM, Racz WJ, McElligott TF. Acetaminophen-induced hepatotoxicity in mice. Lab Invest 1980;42:181-189.
44. Walker RM, Racz WJ, McElligott TF. Acetaminophen-induced hepatotoxic congestion in mice. Hepatology 1985;5:233-240.
45. Farber JL, Gill G, Konishi Y. Prevention of galactosamine-induced liver cell necrosis by uridine. Am J Pathol 1973;72:53-62.
46. Keppler D, Decker K. Studies on the mechanism of galactosamine-1-phosphate and its inhibition of UDP-glucose pyrophosphorylase. Eur J Biochem 1969;10:219-225.
47. Maley F, Tarentino AL, McGarrahan JF, DelGiacco R. The metabolism of D-galactosamine and N-acetyl-D-galactosamine in rat liver [abstract]. J Biochem 1968;107:637A.
48. Shinozuka H, Farber JL, Konishi Y, Anukarahanonta T. D-Galactosamine and acute liver cell injury. Fed Proc 1973;32:1516-1526.
49. Reed D. Chemical mechanisms in drug-induced liver injury. In: Zakim D, Boyer T (eds). Hepatology. Philadelphia: Saunders; 1990:737-753.
50. Corcoran GB, Micchell JR, Vaishnav YN, Horning EC. Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine. Mol Pharmacol 1980;18:536-542.
51. Roberts DW, Bucci TJ, Benson RW, Warbritton AR, McRae TA, Pumford NR, et al. Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity. Am J Pathol 1991;138: 359-371.
52. Aikawa K, Satoh T, Kitagawa H. Comparison of effects of acetaminophen on liver microsomal drug metabolism and lipid peroxidation in rats and mice. Jpn J Pharmacol 1978;28:485-491.
53. Chiu S, Bhakthan N. Experimental acetaminophen-induced hepatic necrosis: Biochemical and electron microscopic study of cysteamine protection. Lab Invest 1978;39:193-203.
54. Mitchell JR, Jollow D, Potter W, Davis D. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 1973;187:185-194.
55. Davis D, Potter W, Jollow D, Mitchell JR. Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sci 1974;14:2099-2109.
56. Walker RM, Massey TE, McElligott TF, Racz WJ. Acetaminophen toxicity in fed and fasted mice. Can J Physiol Pharmacol 1982;60:399-404.
57. Walker RM, McElligott TF, Massey TE, Racz WJ. Ultrastructural effects of acetaminophen in isolated mouse hepatocytes. Exp Mol Pathol 1983;39:163-175.
58. Prescott L, Roscoe P, Wright N. Plasma paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 1971;1:519-522.
59. Francavilla A, Makowka L, Polimeno L, Barone M, Demetris J, Prelich J, et al. A dog model for acetaminophen-induced fulminant hepatic failure. Gastroenterology 1989;96:470-478.
60. Mitchell JR, Jollow D, Potter W. Acetaminophen-induced necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 1973;187:211-217.
61. Jollow D, Mitchell J, Potter W. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther 1973;187:195-202.
62. Griffith OW, Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem 1979;254:7558-7560.
63. Agar N, Board P. Red cell metabolism. In: Agar N, Board P (eds). Red blood cells of domestic animals. Amsterdam: Elsevier, 1983:27-52.
64. Nash SL, Savides MC, Oehme FW, Johnson DE. The effect of acetaminophen on methemoglobin and blood glutathione parameters in the cat. Toxicology 1984;31:329-334.
65. Savides MC, Oehme FW, Nash SL, Leipold HW. The toxicity and biotransformation of single doses of acetaminophen in dogs and cats. Toxicol Appl Pharmacol 1984;74:26-34.
66. Park CM, Nagel RL. Sulfhemoglobinemia. Clinical and molecular aspects. N Engl J Med 1984;310:1579-1584.
67. Kelner MJ, Bailey DN. Mismeasurement of methemoglobin ("methemoglobin revisited") [letter]. Clin Chem 1985;31:168-169.
68. Mansouri A, Lurie AA. Concise review: Methemoglobinemia. Am J Hematol 1993;42:7-12.
69. Filipponi F, Fabbri LP, Marsili M, Falcini F, Benassai C, Nucera M, et al. A new surgical model of acute liver failure in the pig: Experimental procedure and analysis of liver injury. Eur Surg Res 1991;23:58-64.
70. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445.